Logo
S

Soleno Therapeutics, Inc.

104 employees

Inspired by patients and families around the world, we are researching and developing therapies for rare genetic disorders with a lead candidate in #PraderWilliSyndrome currently under FDA regulatory review. To sign up for updates, visit www.soleno.life.

Investor insights

Funding rounds participated in

$50M sweet spot round size

Investor type

Public Company

Basic info

Industry

Pharmaceutical Manufacturing

Sectors

Pharmaceutical Manufacturing

Funding rounds raised

Total raised

$50M

from 1 investors over 1 rounds

S

Soleno Therapeutics, Inc. raised $50M on January 17, 2025

Investors: Oxford Finance LLC

FAQ